NOVEN ANNOUNCES THIRD QUARTER EARNINGS RELEASE DATE

Back

Miami, FL, October 26, 2006 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced its third quarter 2006 earnings release date.

On November 6, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter ended September 30, 2006. At 9:00 a.m. Eastern Time the same day, a conference call among management and analysts will be broadcast live via the Internet at www.noven.com, and thereafter a rebroadcast will be accessible at the same site for at least two weeks. A taped replay of the call will be available beginning the afternoon of November 6 through November 8 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering account number 286 and conference ID number 217735.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. Noven’s prescription patches are approved in over 30 countries and include Vivelle-Dot™ (the most prescribed estrogen patch in the U.S.) and Daytrana™ (the first and only patch approved for the treatment of ADHD). A range of new patches is under development by Noven in collaboration with industry partners. See www.noven.com for additional information.

Back

Copyright © 2006 Noven Pharmaceuticals, Inc. All rights reserved.